Volume 6 - Special Issue 1 on COVID-19                   Pharm Biomed Res 2020, 6 - Special Issue 1 on COVID-19: 1-4 | Back to browse issues page


XML Print


1- Centre of Excellence in New Target Discovery, Butantan Institute, Sao Paulo, Brazil.
2- Reproduction Group, Medical School, University of Antioquia, Medellín, Colombia.
Abstract:   (3211 Views)
While we are waiting for the “best good news” of a vaccine that allows us to control the SARS-CoV-2 virus that causes COVID-19, we have to find a solution to reduce the adverse effects of the disease on people’s health. The situation is not hopeful. According to the World Health Organization, 4278180 people have been infected, of whom 292376 have died (May 13, 2020), many in their productive age who surely were out of the economic upheavals due to the measures adopted to anticipating the pandemic will also have a negative impact on the world economy.
Full-Text [PDF 385 kb]   (1145 Downloads) |   |   Full-Text (HTML)  (1468 Views)  
Type of Study: Letter to Editor | Subject: General

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.